Oxyresveratrol and Gnetol Glucuronide Metabolites: Chemical Production, Structural Identification, Metabolism by Human and Rat Liver Fractions, and <i>In Vitro</i> Anti-inflammatory Properties
Ruth Hornedo‐Ortega, Michaël Jourdes, Grégory Da Costa, Arnaud Courtois, Julien Gabaston, Pierre‐Louis Teissèdre, Tristan Richard, Stéphanie Krisa
Abstract
High Resolution Image Download MS PowerPoint Slide Stilbene metabolites are attracting great interest because many of them exhibit similar or even stronger biological effects than their parent compounds. Furthermore, the metabolized forms are predominant in biological fluids; therefore, their study is highly relevant. After hemisynthesis production, isolation, and structural elucidation, three glucuronide metabolites for oxyresveratrol (ORV) were formed: trans -ORV-4′- O -glucuronide, trans -ORV-3- O -glucuronide, and trans -ORV-2′- O -glucuronide. In addition, two glucuronide metabolites were obtained for gnetol (GN): trans -GN-2′- O -glucuronide and trans -GN-3- O -glucuronide. When the metabolism of ORV and GN is studied in vitro by human and rat hepatic enzymes, four of the five hemisynthesized compounds were identified and quantified. Human enzymes glucuronidated preferably at the C-2′ position, whereas rat enzymes do so at the C-3 position. In view of these kinetic findings, rat enzymes have a stronger metabolic capacity than human enzymes. Finally, ORV, GN, and their glucuronide metabolites (mainly at the C-3 position) decreased nitric oxide, reactive oxygen species, interleukin 1β, and tumor necrosis factor α production in lipopolysaccharide-stimulated macrophages.